Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
425.2 USD | -1.11% | +3.96% | +4.82% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.82% | 111B | |
+11.16% | 105B | |
-12.41% | 22.34B | |
-3.84% | 21.93B | |
-5.99% | 18.59B | |
-36.52% | 18.12B | |
-10.11% | 16.96B | |
+2.58% | 13.7B | |
+35.96% | 12.45B | |
+290.70% | 7.98B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated Presents at 2022 Wells Fargo Healthcare Conference, Sep-09-2022 11